These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Fatal acute haemolysis in an AIDS patient treated with indinavir. Prazuck T; Semaille C; Roques S AIDS; 1998 Mar; 12(5):531-3. PubMed ID: 9543454 [No Abstract] [Full Text] [Related]
4. [New AIDS study confirms: triple combination therapy with the protease inhibitor indinavir lowers the risk of mortality by 50%]. Praxis (Bern 1994); 1997 May; 86(20):860. PubMed ID: 9312815 [No Abstract] [Full Text] [Related]
5. Milk thistle and indinavir: a randomized controlled pharmacokinetics study and meta-analysis. Mills E; Wilson K; Clarke M; Foster B; Walker S; Rachlis B; DeGroot N; Montori VM; Gold W; Phillips E; Myers S; Gallicano K Eur J Clin Pharmacol; 2005 Mar; 61(1):1-7. PubMed ID: 15666173 [TBL] [Abstract][Full Text] [Related]
6. Administration of indinavir and low-dose ritonavir (800/100 mg twice daily) with food reduces nephrotoxic peak plasma levels of indinavir. Aarnoutse RE; Wasmuth JC; Fätkenheuer G; Schneider K; Schmitz K; de Boo TM; Reiss P; Hekster YA; Burger DM; Rockstroh JK Antivir Ther; 2003 Aug; 8(4):309-14. PubMed ID: 14518700 [TBL] [Abstract][Full Text] [Related]
7. Once-a-day indinavir studied. AIDS Patient Care STDS; 2001 Jun; 15(6):340. PubMed ID: 11529195 [No Abstract] [Full Text] [Related]
8. Indinavir trials stopped. AIDS Patient Care STDS; 1999 Jan; 13(1):59. PubMed ID: 11362090 [No Abstract] [Full Text] [Related]
9. Indinavir nephropathy in an AIDS patient with renal insufficiency and pyuria. Perazella MA; Kashgarian M; Cooney E Clin Nephrol; 1998 Sep; 50(3):194-6. PubMed ID: 9776425 [TBL] [Abstract][Full Text] [Related]
10. [More transparency facilities drug choice in general practice. Booster regimens in direct comparison]. MMW Fortschr Med; 2002 Apr; 144 Suppl 1():82. PubMed ID: 12043090 [No Abstract] [Full Text] [Related]
11. Pharmacokinetics and pharmacodynamics of indinavir with or without low-dose ritonavir in HIV-infected Thai patients. Burger D; Boyd M; Duncombe C; Felderhof M; Mahanontharit A; Ruxrungtham K; Ubolyam S; Stek M; Cooper D; Lange J; Phanupak P; Reiss P J Antimicrob Chemother; 2003 May; 51(5):1231-8. PubMed ID: 12668574 [TBL] [Abstract][Full Text] [Related]
18. Uveitis following administration of the protease inhibitor indinavir to a patient with AIDS. Gariano RF; Cooney EL Clin Infect Dis; 1997 Mar; 24(3):529. PubMed ID: 9114223 [No Abstract] [Full Text] [Related]
19. Protease inhibitor trial started. AIDS Patient Care STDS; 1998 Jan; 12(1):64. PubMed ID: 11361891 [No Abstract] [Full Text] [Related]
20. The use of pharmacokinetically guided indinavir dose reductions in the management of indinavir-associated renal toxicity. Boyd MA; Siangphoe U; Ruxrungtham K; Reiss P; Mahanontharit A; Lange JM; Phanuphak P; Cooper DA; Burger DM J Antimicrob Chemother; 2006 Jun; 57(6):1161-7. PubMed ID: 16595641 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]